乌尔索酸通过调解FABP4/PPARG通路来抑制三阴性乳腺癌的进展
Ying Deng1, Junyi Wu2, Di Pan1
1Department of Traditional Chinese Medicine, Shanghai General Hospital, Shanghai, 200080, China.
European journal of medical research
|July 3, 2025
概括
乌尔索酸 (UA) 通过调节FABP4和增加PPARG表达来抑制三阴性乳腺癌 (TNBC) 细胞生长和迁移. 这为UA提供了基础.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有不良预后的侵袭性亚型.
- 高转移潜力有助于TNBC的致命性.
- 乌尔索酸 (UA) 是一种五环三烯,正在研究其抗瘤作用.
研究的目的:
- 检查乌尔索酸 (UA) 对三阴性乳腺癌 (TNBC) 的抗瘤作用.
- 阐明UA在TNBC行动的基本机制.
- 在TNBC中识别UA的潜在分子标.
主要方法:
- 试验TNBC细胞的增殖和迁移 (CCK-8,伤口愈合).
- 对TNBC和正常组织的转录组分析.
- 在的目标预测 (PubChem,瑞士目标预测).
- 在临床组织和细胞模型中验证FABP4和PPARG表达.
主要成果:
- UA显著抑制了TNBC细胞的增殖和迁移.
- FABP4和PPARG被确定为UA的直接目标.
- 在TNBC组织中观察到FABP4和PPARG的下调.
- UA治疗上调了PPARG,由FABP4调节,提高了UA的疗效.
结论:
- 乌尔索酸 (UA) 显示出作为TNBC治疗剂的潜力.
- 通过通过FABP4调制增加PPARG表达,UA具有抗瘤作用.
- 这些发现支持UA在TNBC治疗中的临床应用.
更多相关视频
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.4K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.3K
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K